doi: 10.1515/jpem-2022-0468 71 Lecka-AmbroziakAWysocka-MincewiczMMarszaek-DziubaKRudzka-KocjanASzaleckiM
On GLP-1, bad habits no longer have the same pull, increasing capability for positive change
Coverage, prior authorization, and savings programs treat them individually
In a statement to NBC News, JC Scott, the president and CEO of the Pharmaceutical Care Management Association, a trade group that represents PBMs, said, "Drug manufacturers alone set and raise drug prices and thats the root cause of high drug costs for patients." Sarah Ryan, a spokesperson for the Pharmaceutical Research and Manufacturers of America, a trade group that represents the drug industry, said insurance companies and PBMs should "acknowledge their role in determining what medicines people can get and how much they pay for them at the pharmacy." How Cost Plus can cut costs One way the cost of drugs can be reduced is by allowing drugmakers to sell directly to pharmacies, said Eric Tichy, division chair of pharmacy supply solutions for the Mayo Clinic in Rochester, Minnesota
PRRG4 regulates mitochondrial function and promotes migratory behaviors of breast cancer cells through the Src-STAT3-POLG axis
2: chi-squared